Patent · US Active

Thrombopoietin activity modulating compounds and methods

US7691895B2 · kind B2 · utility

0Cited by

35References

20Claims

0Family size

Assignee

Ligand Pharmaceuticals Incorporated · US

Inventors

Jyun-Hung Chen · San Diego, US
E. Adam Kallel · Escondido, US
Thomas Lau · San Diego, US
Matthew McNeill · San Clemente, US
Todd Anthony Miller · Encinitas, US
Bao Nguyen · San Diego, US
Richard J. Penulian · San Diego, US
Dean Phillips · San Marcos, US
Daniel A. Ruppar · San Antonio, US
Lin Zhi · San Diego, US
Jackline E. Dalgard · Del Mar, US

Key dates

Filing date	Nov 8, 2007
Grant date	Apr 6, 2010
Priority date	—
Expiry date	Nov 8, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed herein are compounds of Formula (I), (II), and (III)pharmaceutical compositions comprising the same, methods of modulating the activity a thrombopoietin receptor using the same, methods of identifying compounds as thrombopoietin receptor modulators, and methods of treating disease by administering a compound of the invention to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.